How Safe Is Minimally Invasive Transforaminal Lumbar Interbody Fusion for Octogenarians?: A Perioperative Complication Analysis.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
07 2020
Historique:
received: 07 12 2019
revised: 15 04 2020
accepted: 17 04 2020
pubmed: 29 4 2020
medline: 24 10 2020
entrez: 29 4 2020
Statut: ppublish

Résumé

Technical advances in minimally invasive spine surgery have reduced blood loss, access trauma, and postoperative length of stay. However, operating on the susceptible group of octogenarians still poses a dilemma because of a plethora of age-related comorbidities. The aim of this study was to investigate the safety of minimally invasive surgery (MIS) transforaminal lumbar interbody fusion (TLIF) in octogenarians. We conducted a retrospective single-center study of all patients over 80 years of age who, between March 2009 and February 2014, had undergone MIS TLIF. The primary outcome was recorded major and minor complications within 30 days of surgery. Twenty-one patients with an average age of 84.1 ± 2.7 years underwent MIS TLIF in 31 levels for degenerative lumbar disk disease with intolerable pain after failure of conservative treatment. Of the patients, 33.3% showed no perioperative complications. In the remaining 66.7%, 6 major complications and 24 minor complications occurred within 30 days of surgery. Two of these patients died within 30 days of surgery because of sepsis and pulmonary embolism (mortality rate 9.5%). Our study spotlighted the susceptible group of octogenarians and evaluated the safety of MIS TLIF. The perioperative morbidity for octogenarians undergoing MIS TLIF is substantial and even higher than for patients over 65 years of age. Two thirds of patients in this subgroup suffer at least 1 complication. The 30-day mortality rate was 9.5%. Therefore, it is advisable for these patients to exploit all available conservative options prior to surgery.

Sections du résumé

BACKGROUND
Technical advances in minimally invasive spine surgery have reduced blood loss, access trauma, and postoperative length of stay. However, operating on the susceptible group of octogenarians still poses a dilemma because of a plethora of age-related comorbidities. The aim of this study was to investigate the safety of minimally invasive surgery (MIS) transforaminal lumbar interbody fusion (TLIF) in octogenarians.
METHODS
We conducted a retrospective single-center study of all patients over 80 years of age who, between March 2009 and February 2014, had undergone MIS TLIF. The primary outcome was recorded major and minor complications within 30 days of surgery.
RESULTS
Twenty-one patients with an average age of 84.1 ± 2.7 years underwent MIS TLIF in 31 levels for degenerative lumbar disk disease with intolerable pain after failure of conservative treatment. Of the patients, 33.3% showed no perioperative complications. In the remaining 66.7%, 6 major complications and 24 minor complications occurred within 30 days of surgery. Two of these patients died within 30 days of surgery because of sepsis and pulmonary embolism (mortality rate 9.5%).
CONCLUSIONS
Our study spotlighted the susceptible group of octogenarians and evaluated the safety of MIS TLIF. The perioperative morbidity for octogenarians undergoing MIS TLIF is substantial and even higher than for patients over 65 years of age. Two thirds of patients in this subgroup suffer at least 1 complication. The 30-day mortality rate was 9.5%. Therefore, it is advisable for these patients to exploit all available conservative options prior to surgery.

Identifiants

pubmed: 32344141
pii: S1878-8750(20)30835-4
doi: 10.1016/j.wneu.2020.04.128
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e754-e760

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Ioannis Vasilikos (I)

Department of Neurosurgery, Medical Centre, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Electronic address: ioannisvasilikos@icloud.com.

Panagiotis Fistouris (P)

Department of Neurosurgery, Medical Centre, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Marie Therese Krüger (MT)

Department of Neurosurgery, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Christoph Scholz (C)

Department of Neurosurgery, Medical Centre, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Evangelos Kogias (E)

Department of Neurosurgery, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Roland Roelz (R)

Department of Neurosurgery, Medical Centre, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Ronen Sircar (R)

Department of Neurosurgery, Medical Centre, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Jürgen Beck (J)

Department of Neurosurgery, Medical Centre, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Ulrich Hubbe (U)

Department of Neurosurgery, Medical Centre, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Jan-Helge Klingler (JH)

Department of Neurosurgery, Medical Centre, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH